You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 4, April 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Pitfalls in the Interpretation of Serum Theophylline Levels

Carin Lam, MD; Zvi Ben-Zvi, MD; Scott Barnett, MD; Meyer Kattan, MD, CM

Am J Dis Child. 1982;136(4):345-347.


Abstract

• In two groups of patients, noncompliance with drug regimens resulted in misinterpretation of serum theophylline levels. All six chronic asthmatics in the first group, found in a retrospective review of 43 outpatient charts, had outpatient serum theophylline levels in the therapeutic range (10 to 20 µg/mL) and at least a 7-µg/mL greater inpatient theophylline level while receiving the same dosage. When hospitalized, four of these patients had serum theophylline levels in the toxic range (> 20 µg/mL). In the second group, four hospitalized patients had persistently low serum theophylline levels despite an adequate theophylline dose. When compliance was enforced, serum theophylline levels rose significantly. Compliance cannot be assumed in the outpatient with a serum theophylline level in the therapeutic range or in the hospitalized patient. Determination of serum theophylline level after supervised drug administration is recommended in inpatients requiring unusually high doses of theophylline or in those whose condition is poorly controlled despite having serum theophylline levels in the therapeutic range (10 to 20 µg/mL).

(Am J Dis Child 1982;136:345-347)



Author Affiliations

From the Pediatric Pulmonary Center, Department of Pediatrics, Mt Sinai School of Medicine, New York. Dr Lam is a clinical fellow of the Cystic Fibrosis Foundation.


Footnotes

Reprint requests to Pediatric Pulmonary Center, Department of Pediatrics, Mt Sinai School of Medicine, 1 Gustave L. Levy PI, New York, NY 10029 (Dr Kattan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.